Non-viral based miR delivery and recent developments

作者：Labatut Annalise Elizabeth; Mattheolabakis George^*

来源：European Journal of Pharmaceutics and Biopharmaceutics, 2018, 128: 82-90.

DOI：10.1016/j.ejpb.2018.04.018

• Nanoparticles
• Non-viral vectors
• miRNA therapeutics
• Delivery

miRNAs are promising therapeutic targets or tools for the treatment of numerous diseases, with most prominently, cancer. The inherent capacity of these short nucleic acids to regulate multiple cancer-related pathways simultaneously has prompted strong research on understanding miR functions and their potential use for therapeutic purposes. A key determinant of miR therapeutics' potential for treatment is their delivery. Viral and non-viral vectors attempt to address the major limitations associated with miR delivery, but several hurdles have been identified. Here, we present an overview on the general limitations of miR delivery, and the delivery strategies exploited to overcome them. We provide an introduction on the advantages and disadvantages of viral and non-viral vectors, and we go into detail to analyze the most prominently used non-viral systems. We provide with an update on the most recent research on this topic and we describe the mechanism and limitations of the lipid-, polymer- and inorganic material- based miR delivery systems.

• 出版日期2018-7